A Three-Variable Survival Model in Blast and Accelerated Phase Myeloproliferative Neoplasms Treated with Venetoclax and Hypomethylating Agents
Gangat N, Warraich M, Kumar S, Fatima M, McCullough K, Begna KH, Al-Kali A, Patnaik MM, Litzow MR, Hogan WJ, Mangaonkar A, Alkhateeb H, Shah MV, Elliott MA, Foran JM, Badar T, Palmer JM, Arana Yi C, Pardanani A, Tefferi A. Haematologica
Retrospective Cohort